Indicators

Latest News about AbbVie Inc

Recent news which mentions AbbVie Inc

< Previous 1 2 Next >

Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat

May 07, 2025

Trump signs order to boost domestic drug manufacturing as pharma tariff threat looms

May 05, 2025

Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit

May 02, 2025

Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom

April 30, 2025

Cramer's week ahead: Earnings from Tesla, Alphabet, Capital One and Boeing

April 17, 2025

Pharmaceutical stocks fall as Trump doubles down on tariffs threat

April 09, 2025

Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks

April 01, 2025

Ad spending on women's sports more than doubled last year

March 11, 2025

Healthy Returns: AbbVie is the newest potential weight loss drug market player

March 04, 2025

Cramer's Lighting Round: AbbVie is a buy

February 04, 2025

Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

January 17, 2025

Wednesday's big stock stories: What’s likely to move the market in the next trading session

October 29, 2024

Cramer's Lightning Round: Sweetgreen is 'terrific'

October 16, 2024

Friday's big stock stories: What’s likely to move the market in the next trading session

August 22, 2024

Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations

August 15, 2024

Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare

August 06, 2024

Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors

May 01, 2024

AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez

February 20, 2024

After 8 months stuck in orbit, Varda's drug spacecraft gets FAA approval to return

February 14, 2024

Cramer's Lightning Round: AbbVie is 'a very good company'

February 08, 2024

Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs

January 28, 2024

J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion

January 08, 2024

Cramer names biopharma companies to watch as industry mergers start to pile up

January 05, 2024

Pfizer shares fall as 2024 revenue and profit forecast disappoints

December 13, 2023

5 things to know before the stock market opens Thursday

December 07, 2023

AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion

December 06, 2023

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion

November 30, 2023

Here are 16 stocks Jim Cramer is watching, including Microsoft, Chevron, Southwest

October 30, 2023

Cramer's Lightning Round: Energy Transfer is a buy

October 13, 2023

Drugmakers opt in to Medicare drug price negotiations – here's what happens next

October 02, 2023

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.